$NRXP $3.29 +4.78% New Data on Infection Avoidance and Development of pH Neutral Ketamine, for Intravenous & Subcutaneous Use NASDAQ: NRXP https://www.einpresswire.com/article/704132993/new-data-on-infection-avoidance-and-development-of-ph-neutral-ketamine-for-intravenous-subcutaneous-use-nasdaq-nrxp via @ein_news @NRxPharma